Budesonide 400 mcg + Formoterol Fumarate Dihydrate 6 mcg is a combination inhalation therapy used for the long-term management of asthma and chronic obstructive pulmonary disease (COPD). This dual-action formulation combines an inhaled corticosteroid (ICS) with a long-acting beta2-agonist (LABA) to provide both anti-inflammatory and bronchodilator effects. Budesonide reduces airway inflammation, swelling, and mucus production, helping prevent asthma attacks and breathing difficulties. Formoterol works by relaxing the bronchial smooth muscles, resulting in sustained bronchodilation and improved airflow. This combination therapy helps control symptoms such as wheezing, shortness of breath, chest tightness, and coughing. It is intended for maintenance treatment and not for immediate relief of acute bronchospasm.
